DOCSLIB.ORG

Transcription Factors

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Transcription Factors Flexi® ORF Clone www.promega.co.jp/flexiclone/ Transcription Factors 1216個 （2012/4/1 現在） 遺伝子シンボル 説明 FXC_PID 価格 FHC_PID 価格 AATF apoptosis antagonizing transcription factor FXC01868 ¥40,000 FHC01868 ¥50,000 ABT1 activator of basal transcription 1 FXC02664 ¥40,000 FHC02664 ¥50,000 AEBP2 AE binding protein 2, transcript variant 2 FXC30523M ¥90,000 FHC30523M ¥100,000 AFF1 AF4/FMR2 family, member 1 FXC01899 ¥40,000 FHC01899 ¥50,000 AFF4 AF4/FMR2 family, member 4 FXC07632M ¥50,000 FHC07632 ¥50,000 AHR aryl hydrocarbon receptor FXC01249 ¥40,000 FHC01249 ¥50,000 AHRR aryl-hydrocarbon receptor repressor FXC00775 ¥40,000 FHC00775 ¥50,000 ALX1 ALX homeobox 1 FXC24829M ¥50,000 FHC24829 ¥50,000 ALX4 ALX homeobox 4 FXC01180 ¥40,000 FHC01180 ¥50,000 ANP32A acidic (leucine-rich) nuclear phosphoprotein 32 family, FXC02366 ¥40,000 FHC02366 ¥50,000 Androgen receptor (Dihydrotestosterone receptor)(Nuclear AR FXC11949M ¥50,000 FHC11949 ¥50,000 receptor subfamily 3 group C member 4) Androgen receptor (Dihydrotestosterone receptor)(Nuclear AR FXC11950M ¥50,000 FHC11950 ¥50,000 receptor subfamily 3 group C member 4) AR androgen receptor FXC11031M ¥50,000 FHC11031 ¥50,000 ARID1B AT rich interactive domain 1B (SWI1-like) FXC11963M ¥140,000 FHC11963M ¥150,000 ARID3A AT rich interactive domain 3A (BRIGHT-like) FXC11107M ¥50,000 FHC11107 ¥50,000 ARID5B AT rich interactive domain 5B (MRF1-like) FXC11014 ¥40,000 FHC11014 ¥50,000 ARNT aryl hydrocarbon receptor nuclear translocator FXC01533 ¥40,000 FHC01533 ¥50,000 ARNT2 aryl-hydrocarbon receptor nuclear translocator 2 FXC01593 ¥40,000 FHC01593 ¥50,000 Aryl hydrocarbon receptor nuclear translocator-like protein 1 ARNTL (Brain and muscle ARNT-like 1)(Member of PAS protein FXC03462 ¥40,000 FHC03462 ¥50,000 3)(Basic-helix-loop-helix-PAS protein MOP3)(bHLH-PAS ARNTL2 aryl hydrocarbon receptor nuclear translocator-like 2 FXC12305M ¥50,000 FHC12305 ¥50,000 ASCL1 achaete-scute complex homolog 1 (Drosophila) FXC03176 ¥40,000 FHC03176 ¥50,000 ASCL2 achaete-scute complex homolog 2 (Drosophila) FXC24115M ¥50,000 FHC24115 ¥50,000 ASCL3 achaete-scute complex homolog 3 (Drosophila) FXC03178 ¥40,000 FHC03178 ¥50,000 ASH1L ash1 (absent, small, or homeotic)-like (Drosophila) FXC12494M ¥50,000 FHC12494 ¥50,000 ASH2L ash2 (absent, small, or homeotic)-like (Drosophila) FXC01483 ¥40,000 FHC01483 ¥50,000 ATF1 activating transcription factor 1 FXC10950M ¥50,000 FHC10950 ¥50,000 ATF2 activating transcription factor 2 FXC01751 ¥40,000 FHC01751 ¥50,000 Cyclic AMP-dependent transcription factor ATF-3 (cAMP- ATF3 dependent transcription factor ATF-3)(Activating transcription FXC08278 ¥40,000 FHC08278 ¥50,000 factor 3) activating transcription factor 4 (tax-responsive enhancer ATF4 FXC04200 ¥40,000 FHC04200 ¥50,000 element B67) ATF5 activating transcription factor 5 FXC02605 ¥40,000 FHC02605 ¥50,000 ATF6 activating transcription factor 6 FXC20682M ¥90,000 FHC20682M ¥100,000 ATF7 activating transcription factor 7 FXC03273 ¥40,000 FHC03273 ¥50,000 ATOH1 atonal homolog 1 (Drosophila) FXC03179 ¥40,000 FHC03179 ¥50,000 ATOH8 atonal homolog 8 (Drosophila) FXC02368 ¥40,000 FHC02368 ¥50,000 alpha thalassemia/mental retardation syndrome X-linked, ATRX FXC12303M ¥150,000 FHC12303M ¥160,000 transcript variant 1 BTB and CNC homology 1, basic leucine zipper transcription BACH1 FXC01715 ¥40,000 FHC01715 ¥50,000 factor 1 BTB and CNC homology 1, basic leucine zipper transcription BACH2 FXC10469 ¥40,000 FHC10469 ¥50,000 factor 2 BANP BTG3 associated nuclear protein FXC09951M ¥50,000 FHC09951 ¥50,000 BARHL1 BarH-like homeobox 1 FXC03258 ¥40,000 FHC03258 ¥50,000 BARHL2 BarH-like homeobox 2 FXC20405M ¥50,000 FHC20405 ¥50,000 BARX2 Homeobox protein BarH-like 2 FXC03756 ¥40,000 FHC03756 ¥50,000 BATF basic leucine zipper transcription factor, ATF-like FXC02486 ¥40,000 FHC02486 ¥50,000 BATF3 basic leucine zipper transcription factor, ATF-like 3 FXC02490 ¥40,000 FHC02490 ¥50,000 BAZ2A bromodomain adjacent to zinc finger domain, 2A FXC10761 ¥40,000 FHC10761 ¥50,000 BCL11A B-cell CLL/lymphoma 11A (zinc finger protein) FXC00923 ¥40,000 FHC00923 ¥50,000 BCL6 B-cell CLL/lymphoma 6 FXC01416 ¥40,000 FHC01416 ¥50,000 BCL6B B-cell CLL/lymphoma 6, member B (zinc finger protein) FXC02560 ¥40,000 FHC02560 ¥50,000 BCLAF1 BCL2-associated transcription factor 1 FXC00033 ¥40,000 FHC00033 ¥50,000 BLZF1 basic leucine zipper nuclear factor 1 FXC02588 ¥40,000 FHC02588 ¥50,000 BMI1 BMI1 polycomb ring finger oncogene FXC04276 ¥40,000 FHC04276 ¥50,000 BNC1 basonuclin 1 FXC04279M ¥50,000 FHC04279 ¥50,000 BRD1 bromodomain containing 1 FXC02120 ¥40,000 FHC02120 ¥50,000 BRD2 bromodomain containing 2 FXC01342 ¥40,000 FHC01342 ¥50,000 BRD3 bromodomain containing 3 FXC00382 ¥40,000 FHC00382 ¥50,000 BRD4 Bromodomain-containing protein 4 FXC11882M ¥50,000 FHC11882 ¥50,000 Bromodomain-containing protein 7 (75 kDa bromodomain BRD7 FXC01947 ¥40,000 FHC01947 ¥50,000 protein)(Protein CELTIX-1) BRDT bromodomain, testis-specific FXC03287 ¥40,000 FHC03287 ¥50,000 プロメガ株式会社 TEL. 03-3669-7981 納期はProduct ID (PID)が赤色のものは約2ヶ月、その他は約２週間です。 Flexi® ORF Clone www.promega.co.jp/flexiclone/ Transcription factor IIIB 90 kDa subunit BRF1 (TFIIIB90)(hTFIIIB90)(B-related factor 1)(BRF- FXC10464 ¥40,000 FHC10464 ¥50,000 1)(hBRF)(TATA box-binding protein-associated factor, RNA Transcription factor IIIB 50 kDa subunit BRF2 FXC04286 ¥40,000 FHC04286 ¥50,000 (TFIIIB50)(hTFIIIB50)(B-related factor 2)(BRF-2)(hBRFU) BRPF1 bromodomain and PHD finger containing, 1 FXC01228 ¥40,000 FHC01228 ¥50,000 BRPF3 bromodomain and PHD finger containing, 3 FXC01683 ¥40,000 FHC01683 ¥50,000 BTBD1 BTB (POZ) domain containing 1 FXC02872 ¥40,000 FHC02872 ¥50,000 BTBD2 BTB (POZ) domain containing 2 FXC10757 ¥40,000 FHC10757 ¥50,000 BTBD3 BTB (POZ) domain containing 3 FXC00694 ¥40,000 FHC00694 ¥50,000 BTBD6 BTB (POZ) domain containing 6 FXC31515M ¥50,000 FHC31515 ¥50,000 BTF3 basic transcription factor 3 FXC02655 ¥40,000 FHC02655 ¥50,000 C11orf9 chromosome 11 open reading frame 9 FXC01138 ¥40,000 FHC01138 ¥50,000 CAND1 cullin-associated and neddylation-dissociated 1 FXC01125 ¥40,000 FHC01125 ¥50,000 Protein CBFA2T2 (MTG8-related protein 1)(MTG8-like CBFA2T2 protein)(Myeloid translocation-related protein 1)(ETO FXC03455 ¥40,000 FHC03455 ¥50,000 homologous on chromosome 20)(p85) Protein CBFA2T3 (Myeloid translocation gene on CBFA2T3 chromosome 16 protein)(hMTG16)(MTG8-related protein FXC03597 ¥40,000 FHC03597 ¥50,000 2)(Zinc finger MYND domain-containing protein 4) Chromobox protein homolog 1 (Heterochromatin protein 1 CBX1 homolog beta)(HP1 beta)(Modifier 1 FXC07438 ¥40,000 FHC07438 ¥50,000 protein)(M31)(Heterochromatin protein CBX2 chromobox homolog 2 (Pc class homolog, Drosophila) FXC03278 ¥40,000 FHC03278 ¥50,000 CBX3 chromobox homolog 3 (HP1 gamma homolog, Drosophila) FXC02188 ¥40,000 FHC02188 ¥50,000 CBX4 chromobox homolog 4 (Pc class homolog, Drosophila) FXC04445 ¥40,000 FHC04445 ¥50,000 CBX5 chromobox homolog 5 (HP1 alpha homolog, Drosophila) FXC10519 ¥40,000 FHC10519 ¥50,000 CBX7 chromobox homolog 7 FXC10535 ¥40,000 FHC10535 ¥50,000 CBX8 chromobox homolog 8 (Pc class homolog, Drosophila) FXC01705 ¥40,000 FHC01705 ¥50,000 CDX1 caudal type homeobox 1 FXC03255 ¥40,000 FHC03255 ¥50,000 CDX2 caudal type homeobox 2 FXC02540 ¥40,000 FHC02540 ¥50,000 CDX4 caudal type homeobox 4 FXC27424M ¥50,000 FHC27424 ¥50,000 CEBPA CCAAT/enhancer-binding protein alpha FXC10825M ¥50,000 FHC10825 ¥50,000 CEBPB CCAAT/enhancer binding protein (C/EBP), beta FXC03181 ¥40,000 FHC03181 ¥50,000 CEBPD CCAAT/enhancer binding protein (C/EBP), delta FXC23262M ¥50,000 FHC23262 ¥50,000 CEBPE CCAAT/enhancer-binding protein epsilon (C/EBP epsilon) FXC06663 ¥40,000 FHC06663 ¥50,000 CEBPG CCAAT/enhancer binding protein (C/EBP), gamma FXC03182 ¥40,000 FHC03182 ¥50,000 CENPH centromere protein H FXC08778M ¥50,000 FHC08778 ¥50,000 CHD2 chromodomain helicase DNA binding protein 2 FXC31523M ¥50,000 FHC31523 ¥50,000 CHD4 chromodomain helicase DNA binding protein 4 FXC11086M ¥50,000 FHC11086 ¥50,000 CHD5 Chromodomain-helicase-DNA-binding protein 5 FXC04548 ¥40,000 FHC04548 ¥50,000 CHD6 chromodomain helicase DNA binding protein 6 FXC11090M ¥50,000 FHC11090 ¥50,000 CIAO1 cytosolic iron-sulfur protein assembly 1 homolog (S. FXC02084 ¥40,000 FHC02084 ¥50,000 CIC capicua homolog (Drosophila) FXC11744 ¥40,000 FHC11744 ¥50,000 CIITA class II, major histocompatibility complex, transactivator FXC25588M ¥100,000 FHC25588M ¥110,000 Cbp/p300-interacting transactivator, with Glu/Asp-rich CITED1 FXC03083 ¥40,000 FHC03083 ¥50,000 carboxy-terminal domain, 1 Cbp/p300-interacting transactivator, with Glu/Asp-rich CITED2 FXC03180 ¥40,000 FHC03180 ¥50,000 carboxy-terminal domain, 2 CLOCK clock homolog (mouse) FXC00509 ¥40,000 FHC00509 ¥50,000 CNBP CCHC-type zinc finger, nucleic acid binding protein FXC02504 ¥40,000 FHC02504 ¥50,000 CNOT3 CCR4-NOT transcription complex, subunit 3 FXC01111 ¥40,000 FHC01111 ¥50,000 CNOT4 CCR4-NOT transcription complex, subunit 4 FXC01860 ¥40,000 FHC01860 ¥50,000 CNOT8 CCR4-NOT transcription complex, subunit 8 FXC02751 ¥40,000 FHC02751 ¥50,000 COP9 constitutive photomorphogenic homolog subunit 2 COPS2 FXC04609 ¥40,000 FHC04609 ¥50,000 (Arabidopsis) COP9 constitutive photomorphogenic homolog subunit 5 COPS5 FXC02690 ¥40,000 FHC02690 ¥50,000 (Arabidopsis) CREB1 cAMP responsive element binding protein 1 FXC00339 ¥40,000 FHC00339 ¥50,000 CREB3 cAMP responsive element binding protein 3 FXC02549 ¥40,000 FHC02549 ¥50,000 CREB3L1 cAMP responsive element binding protein 3-like 1 FXC04624 ¥40,000 FHC04624 ¥50,000 CREB3L2 cAMP responsive element binding protein 3-like 2 FXC04625 ¥40,000 FHC04625 ¥50,000 CREB3L3 cAMP responsive element binding protein 3-like 3 FXC26402M ¥50,000 FHC26402 ¥50,000 Cyclic AMP-responsive element-binding protein 3-like protein 4 (cAMP-responsive element-binding protein 3-like protein 4)(Cyclic AMP-responsive element-binding protein 4)(cAMP- responsive element-binding protein 4)(CREB-4)(Androgen- CREB3L4 FXC03678 ¥40,000 FHC03678 ¥50,000 induced basic leucine zipper protein)(AIbZIP)(Attaching to CRE-like 1)(ATCE1)(Transcript induced in spermiogenesis protein 40)(Tisp40)(hJAL) [Contains Processed cyclic AMP- responsive element-binding protein 3-like protein 4] プロメガ株式会社 TEL.
Load more

Recommended publications
  • A Genetic Screening Identifies a Component of the SWI/SNF Complex, Arid1b As a Senescence Regulator
    A genetic screening identifies a component of the SWI/SNF complex, Arid1b as a senescence regulator Sadaf Khan A thesis submitted to Imperial College London for the degree of Doctor in Philosophy MRC Clinical Sciences Centre Imperial College London, School of Medicine July 2013 Statement of originality All experiments included in this thesis were performed by myself unless otherwise stated. Copyright Declaration The copyright of this thesis rests with the author and is made available under a Creative Commons Attribution Non-Commercial No Derivatives license. Researchers are free to copy, distribute or transmit the thesis on the condition that they attribute it, that they do not use it for commercial purposes and that they do not alter, transform or build upon it. For any reuse or redistribution, researchers must make clear to others the license terms of this work. 2 Abstract Senescence is an important tumour suppressor mechanism, which prevents the proliferation of stressed or damaged cells. The use of RNA interference to identify genes with a role in senescence is an important tool in the discovery of novel cancer genes. In this work, a protocol was established for conducting bypass of senescence screenings, using shRNA libraries together with next-generation sequencing. Using this approach, the SWI/SNF subunit Arid1b was identified as a regulator of cellular lifespan in MEFs. SWI/SNF is a large multi-subunit complex that remodels chromatin. Mutations in SWI/SNF proteins are frequently associated with cancer, suggesting that SWI/SNF components are tumour suppressors. Here the role of ARID1B during senescence was investigated. Depletion of ARID1B extends the proliferative capacity of primary mouse and human fibroblasts.
    [Show full text]
  • Supplementary Materials: Evaluation of Cytotoxicity and Α-Glucosidase Inhibitory Activity of Amide and Polyamino-Derivatives of Lupane Triterpenoids
    Supplementary Materials: Evaluation of cytotoxicity and α-glucosidase inhibitory activity of amide and polyamino-derivatives of lupane triterpenoids Oxana B. Kazakova1*, Gul'nara V. Giniyatullina1, Akhat G. Mustafin1, Denis A. Babkov2, Elena V. Sokolova2, Alexander A. Spasov2* 1Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences, 71, pr. Oktyabrya, 450054 Ufa, Russian Federation 2Scientific Center for Innovative Drugs, Volgograd State Medical University, Novorossiyskaya st. 39, Volgograd 400087, Russian Federation Correspondence Prof. Dr. Oxana B. Kazakova Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences 71 Prospeсt Oktyabrya Ufa, 450054 Russian Federation E-mail: [email protected] Prof. Dr. Alexander A. Spasov Scientific Center for Innovative Drugs of the Volgograd State Medical University 39 Novorossiyskaya st. Volgograd, 400087 Russian Federation E-mail: [email protected] Figure S1. 1H and 13C of compound 2. H NH N H O H O H 2 2 Figure S2. 1H and 13C of compound 4. NH2 O H O H CH3 O O H H3C O H 4 3 Figure S3. Anticancer screening data of compound 2 at single dose assay 4 Figure S4. Anticancer screening data of compound 7 at single dose assay 5 Figure S5. Anticancer screening data of compound 8 at single dose assay 6 Figure S6. Anticancer screening data of compound 9 at single dose assay 7 Figure S7. Anticancer screening data of compound 12 at single dose assay 8 Figure S8. Anticancer screening data of compound 13 at single dose assay 9 Figure S9. Anticancer screening data of compound 14 at single dose assay 10 Figure S10.
    [Show full text]
  • TRAINING Datasets HGNC ID ENCODE Dataset ID ARID3A
    TRAINING datasets HGNC ID ENCODE dataset ID ARID3A SydhT+sHepg2Arid3anb100279Iggrab.1000.fasta.summary ARID3A SydhT+sK562Arid3asC8821Iggrab.1000.fasta.summary BACH1 SydhT+sH1hesCBaCh1sC14700Iggrab.1000.fasta.summary BACH1 SydhT+sK562BaCh1sC14700Iggrab.1000.fasta.summary BATF HaibT+sGm12878BaJPCr1x.1000.fasta.summary BHLHE40 HaibT+sHepg2Bhlhe40V0416101.1000.fasta.summary BHLHE40 SydhT+sA549Bhlhe40Iggrab.1000.fasta.summary BHLHE40 SydhT+sGm12878Bhlhe40CIggmus.1000.fasta.summary BHLHE40 SydhT+sHepg2Bhlhe40CIggrab.1000.fasta.summary BHLHE40 SydhT+sK562Bhlhe40nb100Iggrab.1000.fasta.summary BRCA1 SydhT+sH1hesCBrCa1Iggrab.1000.fasta.summary BRCA1 SydhT+sHelas3BrCa1a300Iggrab.1000.fasta.summary CEBPB HaibT+sGm12878CebpbsC150V0422111.1000.fasta.summary CEBPB HaibT+sHepg2CebpbsC150V0416101.1000.fasta.summary CEBPB HaibT+sK562CebpbsC150V0422111.1000.fasta.summary CEBPB SydhT+sA549CebpbIggrab.1000.fasta.summary CEBPB SydhT+sH1hesCCebpbIggrab.1000.fasta.summary CEBPB SydhT+sHelas3CebpbIggrab.1000.fasta.summary CEBPB SydhT+sHepg2CebpbForsklnStd.1000.fasta.summary CEBPB SydhT+sHepg2CebpbIggrab.1000.fasta.summary CEBPB SydhT+sImr90CebpbIggrab.1000.fasta.summary CEBPB SydhT+sK562CebpbIggrab.1000.fasta.summary CEBPD HaibT+sHepg2CebpdsC636V0416101.1000.fasta.summary CREB1 HaibT+sA549Creb1sC240V0416102Dex100nm.1000.fasta.summary CTCF HaibT+sA549CtCfsC5916PCr1xDex100nm.1000.fasta.summary CTCF HaibT+sA549CtCfsC5916PCr1xEtoh02.1000.fasta.summary CTCF HaibT+sECC1CtCfCV0416102Dm002p1h.1000.fasta.summary CTCF HaibT+sH1hesCCtCfsC5916V0416102.1000.fasta.summary
    [Show full text]
  • 1 the Neuroprotective Transcription Factor ATF5 Is Decreased And
    The neuroprotective transcription factor ATF5 is decreased and sequestered into polyglutamine inclusions in Huntington’s disease Ivó H. Hernández1,2,3, Jesús Torres-Peraza1,2,5, María Santos-Galindo1,2, Eloísa Ramos-Morón4, María R. Fernández-Fernández1,2, María J. Pérez-Álvarez1,2,3, Antonio Miranda-Vizuete4 and José J. Lucas1,2* 1 Centro de Biología Molecular Severo Ochoa (CBM”SO”) CSIC/UAM, Madrid, Spain. 2 Instituto de Salud Carlos III, Networking Research Center on Neurodegenerative Diseases (CIBERNED), Spain. 3 Departamento de Biología, Facultad de Ciencias, Universidad Autónoma de Madrid, Madrid, Spain. 4 Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain 5 Present Address: Gerència d’Atenció Primària del Servei de Salut de les Illes Balears (IB-SALUT), Palma, Spain *Corresponding author: José J. Lucas [email protected] http://www.cbm.uam.es/lineas/lucasgroup.htm provided by Digital.CSIC View metadata, citation and similar papers at core.ac.uk CORE brought to you by 1 Abstract Activating transcription factor-5 (ATF5) is a stress-response transcription factor induced upon different cell stressors like fasting, amino-acid limitation, cadmium or arsenite. ATF5 is also induced, and promotes transcription of anti-apoptotic target genes like MCL1, during the unfolded protein response (UPR) triggered by endoplasmic reticulum stress. In the brain, high ATF5 levels are found in gliomas and also in neural progenitor cells, which need to decrease their ATF5 levels for differentiation into mature neurons or glia. This initially led to believe that ATF5 is not expressed in adult neurons. More recently, we reported basal neuronal ATF5 expression in adult mouse brain and its neuroprotective induction during UPR in a mouse model of status epilepticus.
    [Show full text]
  • Roles of the CSE1L-Mediated Nuclear Import Pathway in Epigenetic
    Roles of the CSE1L-mediated nuclear import pathway PNAS PLUS in epigenetic silencing Qiang Donga,b,c, Xiang Lia,b,c, Cheng-Zhi Wangb, Shaohua Xuc, Gang Yuanc, Wei Shaoc, Baodong Liud, Yong Zhengb, Hailin Wangd, Xiaoguang Leic,e,f, Zhuqiang Zhangb,1, and Bing Zhua,b,g,1 aGraduate Program, Peking Union Medical College and Chinese Academy of Medical Sciences, 100730 Beijing, China; bNational Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, 100101 Beijing, China; cNational Institute of Biological Sciences, 102206 Beijing, China; dThe State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, 100085 Beijing, China; eBeijing National Laboratory for Molecular Sciences, Department of Chemical Biology, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China; fPeking-Tsinghua Center for Life Sciences, Peking University, 100871 Beijing, China; and gCollege of Life Sciences, University of Chinese Academy of Sciences, 100049 Beijing, China Edited by Arthur D. Riggs, Beckman Research Institute of City of Hope, Duarte, CA, and approved March 21, 2018 (received for review January 17, 2018) Epigenetic silencing can be mediated by various mechanisms, CSE1L, a key player in the nuclear import pathway, as an es- and many regulators remain to be identified. Here, we report a sential factor for maintaining the repression of many methyl- genome-wide siRNA screening to identify regulators essential for ated genes. Mechanistically, CSE1L functions by facilitating maintaining gene repression of a CMV promoter silenced by DNA the nuclear import of certain cargo proteins that are essential methylation.
    [Show full text]
  • Datasheet PB1029 Anti-AEBP2 Antibody
    Product datasheet Anti-AEBP2 Antibody Catalog Number: PB1029 BOSTER BIOLOGICAL TECHNOLOGY Special NO.1, International Enterprise Center, 2nd Guanshan Road, Wuhan, China Web: www.boster.com.cn Phone: +86 27 67845390 Fax: +86 27 67845390 Email: [email protected] Basic Information Product Name Anti-AEBP2 Antibody Gene Name AEBP2 Source Rabbit IgG Species Reactivity human,mouse,rat Tested Application WB,IHC-P,ICC/IF,FCM Contents 500ug/ml antibody with PBS ，0.02% NaN3 , 1mg BSA and 50% glycerol. Immunogen E.coli-derived human AEBP2 recombinant protein (Position: K424-Q517). Human AEBP2 shares 98.8% amino acid (aa) sequence identity with mouse AEBP2. Purification Immunogen affinity purified. Observed MW 54KD Dilution Ratios Western blot: 1:500-2000 Immunohistochemistry(Paraffin-embedded Section): 1:50-400 Immunocytochemistry/Immunofluorescence (ICC/IF): 1:50-400 Flow cytometry (FCM): 1-3μg/1x106 cells Storage 12 months from date of receipt，-20℃ as supplied.6 months 2 to 8℃ after reconstitution. Avoid repeated freezing and thawing Background Information Adipocyte Enhancer-Binding Protein is a zinc finger protein that in humans is encoded by the evolutionarily well-conserved gene AEBP2. This gene is mapped to 12p12.3. AEBP2 is a DNA-binding transcriptional repressor. It may regulate the migration and development of the neural crest cells through the PRC2-mediated epigenetic mechanism and is most likely a targeting protein for the mammalian PRC2 complex. Reference Anti-AEBP2 Antibody被引用在0文献中。 暂无引用 FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC AND CLINICAL USE. 1 Product datasheet Anti-AEBP2 Antibody Catalog Number: PB1029 BOSTER BIOLOGICAL TECHNOLOGY Special NO.1, International Enterprise Center, 2nd Guanshan Road, Wuhan, China Web: www.boster.com.cn Phone: +86 27 67845390 Fax: +86 27 67845390 Email: [email protected] Selected Validation Data Figure 1.
    [Show full text]
  • Examination of the Transcription Factors Acting in Bone Marrow
    THESIS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (PHD) Examination of the transcription factors acting in bone marrow derived macrophages by Gergely Nagy Supervisor: Dr. Endre Barta UNIVERSITY OF DEBRECEN DOCTORAL SCHOOL OF MOLECULAR CELL AND IMMUNE BIOLOGY DEBRECEN, 2016 Table of contents Table of contents ........................................................................................................................ 2 1. Introduction ............................................................................................................................ 5 1.1. Transcriptional regulation ................................................................................................... 5 1.1.1. Transcriptional initiation .................................................................................................. 5 1.1.2. Co-regulators and histone modifications .......................................................................... 8 1.2. Promoter and enhancer sequences guiding transcription factors ...................................... 11 1.2.1. General transcription factors .......................................................................................... 11 1.2.2. The ETS superfamily ..................................................................................................... 17 1.2.3. The AP-1 and CREB proteins ........................................................................................ 20 1.2.4. Other promoter specific transcription factor families ...................................................
    [Show full text]
  • ARID1B Is a Specific Vulnerability in ARID1A-Mutant Cancers The
    ARID1B is a specific vulnerability in ARID1A-mutant cancers The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation Helming, K. C., X. Wang, B. G. Wilson, F. Vazquez, J. R. Haswell, H. E. Manchester, Y. Kim, et al. 2014. “ARID1B is a specific vulnerability in ARID1A-mutant cancers.” Nature medicine 20 (3): 251-254. doi:10.1038/nm.3480. http://dx.doi.org/10.1038/nm.3480. Published Version doi:10.1038/nm.3480 Accessed February 16, 2015 10:04:32 PM EST Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:12987227 Terms of Use This article was downloaded from Harvard University's DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA (Article begins on next page) NIH Public Access Author Manuscript Nat Med. Author manuscript; available in PMC 2014 September 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Nat Med. 2014 March ; 20(3): 251–254. doi:10.1038/nm.3480. ARID1B is a specific vulnerability in ARID1A-mutant cancers Katherine C. Helming1,2,3,4,*, Xiaofeng Wang1,2,3,*, Boris G. Wilson1,2,3, Francisca Vazquez5, Jeffrey R. Haswell1,2,3, Haley E. Manchester1,2,3, Youngha Kim1,2,3, Gregory V. Kryukov5, Mahmoud Ghandi5, Andrew J. Aguirre5,6,7, Zainab Jagani8, Zhong Wang9, Levi A. Garraway6, William C. Hahn6,7, and Charles W.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • A Clinicopathological and Molecular Genetic Analysis of Low-Grade Glioma in Adults
    A CLINICOPATHOLOGICAL AND MOLECULAR GENETIC ANALYSIS OF LOW-GRADE GLIOMA IN ADULTS Presented by ANUSHREE SINGH MSc A thesis submitted in partial fulfilment of the requirements of the University of Wolverhampton for the degree of Doctor of Philosophy Brain Tumour Research Centre Research Institute in Healthcare Sciences Faculty of Science and Engineering University of Wolverhampton November 2014 i DECLARATION This work or any part thereof has not previously been presented in any form to the University or to any other body whether for the purposes of assessment, publication or for any other purpose (unless otherwise indicated). Save for any express acknowledgments, references and/or bibliographies cited in the work, I confirm that the intellectual content of the work is the result of my own efforts and of no other person. The right of Anushree Singh to be identified as author of this work is asserted in accordance with ss.77 and 78 of the Copyright, Designs and Patents Act 1988. At this date copyright is owned by the author. Signature: Anushree Date: 30th November 2014 ii ABSTRACT The aim of the study was to identify molecular markers that can determine progression of low grade glioma. This was done using various approaches such as IDH1 and IDH2 mutation analysis, MGMT methylation analysis, copy number analysis using array comparative genomic hybridisation and identification of differentially expressed miRNAs using miRNA microarray analysis. IDH1 mutation was present at a frequency of 71% in low grade glioma and was identified as an independent marker for improved OS in a multivariate analysis, which confirms the previous findings in low grade glioma studies.
    [Show full text]
  • Figure S1. Representative Report Generated by the Ion Torrent System Server for Each of the KCC71 Panel Analysis and Pcafusion Analysis
    Figure S1. Representative report generated by the Ion Torrent system server for each of the KCC71 panel analysis and PCaFusion analysis. (A) Details of the run summary report followed by the alignment summary report for the KCC71 panel analysis sequencing. (B) Details of the run summary report for the PCaFusion panel analysis. A Figure S1. Continued. Representative report generated by the Ion Torrent system server for each of the KCC71 panel analysis and PCaFusion analysis. (A) Details of the run summary report followed by the alignment summary report for the KCC71 panel analysis sequencing. (B) Details of the run summary report for the PCaFusion panel analysis. B Figure S2. Comparative analysis of the variant frequency found by the KCC71 panel and calculated from publicly available cBioPortal datasets. For each of the 71 genes in the KCC71 panel, the frequency of variants was calculated as the variant number found in the examined cases. Datasets marked with different colors and sample numbers of prostate cancer are presented in the upper right. *Significantly high in the present study. Figure S3. Seven subnetworks extracted from each of seven public prostate cancer gene networks in TCNG (Table SVI). Blue dots represent genes that include initial seed genes (parent nodes), and parent‑child and child‑grandchild genes in the network. Graphical representation of node‑to‑node associations and subnetwork structures that differed among and were unique to each of the seven subnetworks. TCNG, The Cancer Network Galaxy. Figure S4. REVIGO tree map showing the predicted biological processes of prostate cancer in the Japanese. Each rectangle represents a biological function in terms of a Gene Ontology (GO) term, with the size adjusted to represent the P‑value of the GO term in the underlying GO term database.
    [Show full text]
  • Supplemental Materials ZNF281 Enhances Cardiac Reprogramming
    Supplemental Materials ZNF281 enhances cardiac reprogramming by modulating cardiac and inflammatory gene expression Huanyu Zhou, Maria Gabriela Morales, Hisayuki Hashimoto, Matthew E. Dickson, Kunhua Song, Wenduo Ye, Min S. Kim, Hanspeter Niederstrasser, Zhaoning Wang, Beibei Chen, Bruce A. Posner, Rhonda Bassel-Duby and Eric N. Olson Supplemental Table 1; related to Figure 1. Supplemental Table 2; related to Figure 1. Supplemental Table 3; related to the “quantitative mRNA measurement” in Materials and Methods section. Supplemental Table 4; related to the “ChIP-seq, gene ontology and pathway analysis” and “RNA-seq” and gene ontology analysis” in Materials and Methods section. Supplemental Figure S1; related to Figure 1. Supplemental Figure S2; related to Figure 2. Supplemental Figure S3; related to Figure 3. Supplemental Figure S4; related to Figure 4. Supplemental Figure S5; related to Figure 6. Supplemental Table S1. Genes included in human retroviral ORF cDNA library. Gene Gene Gene Gene Gene Gene Gene Gene Symbol Symbol Symbol Symbol Symbol Symbol Symbol Symbol AATF BMP8A CEBPE CTNNB1 ESR2 GDF3 HOXA5 IL17D ADIPOQ BRPF1 CEBPG CUX1 ESRRA GDF6 HOXA6 IL17F ADNP BRPF3 CERS1 CX3CL1 ETS1 GIN1 HOXA7 IL18 AEBP1 BUD31 CERS2 CXCL10 ETS2 GLIS3 HOXB1 IL19 AFF4 C17ORF77 CERS4 CXCL11 ETV3 GMEB1 HOXB13 IL1A AHR C1QTNF4 CFL2 CXCL12 ETV7 GPBP1 HOXB5 IL1B AIMP1 C21ORF66 CHIA CXCL13 FAM3B GPER HOXB6 IL1F3 ALS2CR8 CBFA2T2 CIR1 CXCL14 FAM3D GPI HOXB7 IL1F5 ALX1 CBFA2T3 CITED1 CXCL16 FASLG GREM1 HOXB9 IL1F6 ARGFX CBFB CITED2 CXCL3 FBLN1 GREM2 HOXC4 IL1F7
    [Show full text]